Download in electronic PDF format for $25



Search the Complete Journal Archives

New England Compounding Center Indictment

Author(s):  Cabaleiro Joe

Issue:  Mar/Apr 2015 - Volume 19, Number 2
View All Articles in Issue

Abstract:  This article is a review of the lapses in compliance with United States Pharmacopeia standards and pharmacy law as alleged by the New England Compounding Center indictment. This indictment was a result of an outbreak of fungal meningitis traced to fungal contamination of compounded methylprednisolone suspension for epidural steroid injections. This article is also intended as a gap analysis for compounders to review compliance at their own facility, and, if necessary, take the appropriate steps to implement best practices.

Related Keywords: Joe Cabaleiro, RPh, United States Pharmacopeia Chapter <797>, New England Compounding Center, criminal charges, indictment, fungal meningitis outbreak, microbiological contamination, compounded sterile preparations, practices and procedures, patient-specific prescriptions, Drug Quality and Security Act, DQSA, best practices, personnel training, state laws, state regulations, quality standards, pharmacy technicians, laboratory cleaning, disinfection standards, surface sampling, fingertip testing, viable air sampling, microorganisms, pathogens, office use, documentation, sterilization, record retention, sterility testing, media-fill testing

Related Categories: ENVIRONMENTAL , LEGAL, STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
New England Compounding Center Indictment Cabaleiro Joe Mar/Apr 2015 94-102 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Newton David W Jul/Aug 2013 283-288 Buy
Misinterpretation of United States Pharmacopeia Chapter <797> McElhiney Linda F Jan/Feb 2012 6-10 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Allen Loyd V Jr, Okeke Claudia C May/Jun 2008 252-257 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C Mar/Apr 2008 136-144 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2008 440-443 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Allen Loyd V Jr, Okeke Claudia C May/Jun 2009 234-238 Buy
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A Jul/Aug 2004 251 Buy